Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.
Target Price
The average target price of FLERIE.ST is 45 and suggests 65% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell